Filing Details

Accession Number:
0001179110-18-006475
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-05-09 16:29:22
Reporting Period:
2018-05-07
Accepted Time:
2018-05-09 16:29:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1597264 Blueprint Medicines Corp BPMC Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1638474 W. Jeffrey Albers C/O Blueprint Medicines Corporation
45 Sidney Street
Cambridge MA 02139
Ceo And President Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-05-07 20,000 $1.87 20,000 No 4 M Direct
Common Stock Disposition 2018-05-07 11,680 $79.15 8,320 No 4 S Direct
Common Stock Disposition 2018-05-07 8,320 $78.56 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2018-05-07 20,000 $0.00 20,000 $1.87
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
955,034 2024-07-30 No 4 M Direct
Footnotes
  1. The exercise reported on this Form 4 was effected pursuant to a trading plan adopted on December 20, 2017 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the "Exchange Act").
  2. The sales reported on this Form 4 were effected pursuant to a trading plan adopted on December 20, 2017 pursuant to Rule 10b5-1 under the Exchange Act.
  3. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.84 to $79.83 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) and (4) to this Form 4.
  4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.06 to $78.83 per share.
  5. This option was granted on July 30, 2014. This option vests as follows: (i) 42,845 shares vested in four installments at a rate of 6,974 shares on September 21, 2016, and 11,957 shares on each of October 21, 2016 and November 21, 2016, and 11,957 on December 21, 2016; (ii) 90,010 shares vested in eight installments at a rate of 6,311 shares on May 21, 2017 and 11,957 shares on each of June 21, 2017, July 21, 2017, August 21, 2017, September 21, 2017, October 21, 2017, November 21, 2017 and December 21, 2017; and (iii) 30,225 shares vest in three installments at a rate of 6,311 shares on May 21, 2018, 11,957 shares on June 21, 2018 and 11,957 shares on July 21, 2018.